Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001282930-04-000003
Filing Date
2004-04-29
Accepted
2004-04-29 14:57:10
Documents
1
Period of Report
2004-04-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 10308
  Complete submission text file 0001282930-04-000003.txt   12234
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PKWY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BIOCRYST PHARMACEUTICALS, INC 2190 PKWY LAKE DRIVE BIRMINGHAM AL 35244
Business Address C/O BIOCRYST PHARMACEUTICALS, INC 2190 PKWY LAKE DRIVE BIRMINGHAM AL 35244 2054444600
BUGG CHARLES E (Reporting) CIK: 0001198765 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 04764455